Emergent BioSolutions Inc.

EBS | NYSE

Price Alert Chart Builder DCF Calculator

$6.55

-$0.25 (-3.68%)

At close: Sep 21, 2026, 4:00 PM ET

$6.55

$0 (0.00%)

After-hours: Sep 21, 2026, 4:18 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	52.6M	-190.6M	-760.5M	-211.6M	230.9M	305.8M
Depreciation & Amortization	95.8M	108.8M	125.1M	143.3M	123.8M	114.5M
Stock-Based Compensation	16.2M	18M	23.1M	45.1M	42.4M	51.8M
Other Working Capital	-9.2M	170.6M	-59.9M	-49.1M	-61.7M	20.6M
Other Non-Cash Items	32.4M	39.3M	485.2M	19.8M	33.5M	58.6M
Deferred Income Tax	-4M	-5.5M	-8.9M	-28.6M	46.9M	-3.3M
Change in Working Capital	-22.4M	88.7M	-70.3M	-2.1M	-156.4M	9.5M
Operating Cash Flow	170.6M	58.7M	-206.3M	-34.1M	321.1M	536.9M
Capital Expenditures	-13.8M	-22.9M	-51.6M	-115.8M	-225M	-141.9M
Cash Acquisitions	n/a	n/a	270.2M	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	83.2M	148.1M	-6.3M	-265.5M	n/a	-10M
Investing Cash Flow	69.4M	125.2M	212.3M	-381.3M	-225M	-151.9M
Debt Repayment	-112.5M	-198.4M	-543.4M	564.2M	-35.9M	62.9M
Common Stock Repurchased	-24.9M	n/a	n/a	-82.1M	-106M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.4M	-900K	-700K	-900K	900K	6.6M
Financial Cash Flow	-136.6M	-190M	-535.7M	481.2M	-141M	69.5M
Net Cash Flow	103.5M	-6.1M	-530.9M	66.3M	-45.2M	453.5M
Free Cash Flow	156.8M	35.8M	-257.9M	-149.9M	96.1M	395M
Adj. Free Cash Flow	140.6M	17.8M	-281M	-195M	53.7M	343.2M
Maintenance CapEx	-13.8M	-22.9M	-51.6M	-115.8M	-117.96M	n/a
Growth CapEx	n/a	n/a	n/a	n/a	-107.04M	-141.9M
Owner Earnings	156.8M	35.8M	-257.9M	-149.9M	203.14M	536.9M